RADIESSE INJECTABLE IMPLANT
FDA premarket approval P050037/S067 · decided 2016-02-22
Approval details
- PMA number
- P050037
- Supplement
- S067
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- RADIESSE INJECTABLE IMPLANT
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Merz North America, Inc.
- Date received
- 2015-12-07
- Decision date
- 2016-02-22
- Days to decision
- 77 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Franksville, WI
- Statement
- Approval for replacing the 28 GA needle with a 27 GA needle in RADIESSE and RADIESSE (+) Lidocaine Kits, and revision to the labeling to reflect the approved 36 month expiration date for 1.5 cc fill volume.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| DESCRIBE PFD Patch (K172689) | Merz North America, Inc. | 2017-11-29 |